product summary
Loading...
company name :
Tocris Bioscience
product type :
chemical
product name :
GSK 2334470
catalog :
4143/10
quantity :
10 mg (also 50 mg)
price :
298 USD
more info or order :
citations: 5
Reference |
---|
Al Ejeh F, Miranda M, Shi W, Simpson P, Song S, Vargas A, et al. Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer. Oncotarget. 2014;5:3145-58 pubmed
|
image
image 1 :

Cat.No. 4143 - GSK 2334470 C25H34N8O CAS No. 1227911-45-6
product information
brand :
Tocris
master code :
4143
SKU :
4143/10
rank :
0.061
product name :
GSK 2334470
description :
Highly potent, selective PDPK1 (PDK1) inhibitor
target :
PDK-1 Inhibitors
category :
Small Molecules
sizes available :
10 mg (also 50 mg)
url print :
?utm_source=biocompare&utm_medium=referral&utm_campaign=product&utm_term=smallmolecules
details of functionality :
GSK 2334470 is a potent 3-phosphoinositide-dependent protein kinase (PDPK1) inhibitor (IC50 ~ 10 nM). Exhibits no effect on other kinases including Aurora, ROCK, p38 MAPK and PI 3-K. Suppresses T-loop phosphorylation and subsequent activation of PDK1 substrates S6K1, SGK and RSK in vitro ; exhibits limited inhibitory effect on Akt activation. Delays melanomagenesis and metastasis in BrafV600E::Pten(-/-) mice.
extended description :
Highly potent, selective PDPK1 (PDK1) inhibitor
chemical name text :
(3S,6R)-1-[6-(3-Amino-1H-indazol-6-yl)-2-(methylamino)-4-pyrimidinyl]-N-cyclohexyl-6-methyl-3-piperidinecarboxamide
formula :
C 25 H 34 N 8 O
formula text :
C25H34N8O
cas num :
1227911-45-6
USD :
298 USD
product details :
Highly potent, selective PDPK1 (PDK1) inhibitor
storage :
Store the unopened product at 2 - 8 °C. Do not use past expiration date.
more info or order :
company information

Tocris Bioscience
The Watkins Building
Atlantic Road
Avonmouth, Bristol
BS11 9QD
Atlantic Road
Avonmouth, Bristol
BS11 9QD
info@bio-techne.com
https://www.tocris.com800-343-7475
headquarters: UK
browse more products
questions and comments